Dr. Jonathan Pierce Walgama, MD

Dr. Walgama practices at Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana, part of Veterans Health Administration.

Dr. Walgama's NPI, 1477846871, was assigned on May 18, 2011. Dr. Walgama graduated from Texas A&M College of Medicine - Bryan in 2011. Dr. Walgama holds Texas license Q3122.

Dr. Walgama's primary practice is Overton Brooks Veterans' Administration Medical Center, at 510 East Stoner Avenue, Shreveport, LA 71101 in Caddo Parish. The practice phone is (318) 424-6037.

Dr. Walgama's primary practice is Overton Brooks Veterans' Administration Medical Center in Shreveport, Louisiana, part of Veterans Health Administration. Dr. Walgama is also affiliated with CHRISTUS Good Shepherd Medical Center - Longview. Dmand AI also links Dr. Walgama to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walgama practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Walgama's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Walgama is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Walgama's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Walgama treats.

CMS data shows 3,225 Medicare services from Dr. Walgama across 20 procedure codes in 2024, for 940 Medicare patients. Medicare paid $263,303 for them.

CMS counts 940 Medicare patients who saw Dr. Walgama in 2024. The largest group is 65 to 74, with 437 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Walgama's median patient age at 75, with 59% women.

In 2024, Dr. Walgama wrote 1,241 Medicare Part D claims for 319 patients. 63% of them were for generic drugs. CMS names the drug for 1,151 of them, across 12 drugs with 11 or more claims each, at $41,466 in total drug cost. In 2023, CMS named 908 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Walgama for performance year 2024, reported individually. Dr. Walgama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 286 procedures of cataract surgery by Dr. Walgama, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Walgama. Dr. Walgama's most frequent co-authors are Mark Edwin Kunik, MD, MPH and Paul E. Schulz, MD.

CMS Open Payments shows 51 general payments to Dr. Walgama from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. RxSight Inc paid the most, $8,221.

Dr. Walgama graduated from Texas A&M College of Medicine - Bryan in 2011.

Dr. Walgama is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.